Pimstone, Simon Neil

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
15 47% Buy
34 71% Buy
47 69% Buy
Pimstone, Simon Neil's trades of Eupraxia Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-27 2026-03-27 B Purchase
11,383 -46.8%
106.98
CA$2,564,514
11,383 -46.8% 106.98 CA$2,564,514
2026-03-27 2026-03-27 B Purchase
37,090 +46.7%
264.25
CA$2,323,864
37,090 +46.7% 264.25 CA$2,323,864
2026-03-27 2026-03-27 B Purchase
32,888 -8.5%
288.46
CA$4,850,990
32,888 -8.5% 288.46 CA$4,850,990
2026-03-27 2026-03-27 B Purchase
2,000 +5.7%
9.40
CA$18,800
2,000 +5.7% 9.40 CA$18,800
2026-03-27 2026-03-27 B Purchase
2,500 +7.7%
9.39
CA$23,475
2,500 +7.7% 9.39 CA$23,475
2025-09-24 2025-09-24 B Purchase
3,052 +66.0%
5.50
US$16,786
3,052 +66.0% 5.50 US$16,786
2023-08-20 2023-08-18 B Purchase
4,000 +86.5%
7.00
CA$28,000
4,000 +86.5% 7.00 CA$28,000
2023-03-09 2023-03-07 S Sale
8,242 -13.0%
36.94
US$304,459
8,242 -13.0% 36.94 US$304,459
2023-03-09 2023-03-07 S Sale
10,990 -24.4%
37.01
US$406,740
10,990 -24.4% 37.01 US$406,740
2022-08-16 2022-08-16 S Sale
20,000 -76.9%
38.87
US$777,400
20,000 -76.9% 38.87 US$777,400
2022-08-16 2022-08-16 S Sale
32,058 -55.2%
38.29
US$1,227,501
32,058 -55.2% 38.29 US$1,227,501
2022-08-16 2022-08-15 S Sale
33,942 -36.9%
37.76
US$1,281,650
33,942 -36.9% 37.76 US$1,281,650
2022-08-16 2022-08-12 S Sale
1,000 -1.1%
39.15
US$39,150
1,000 -1.1% 39.15 US$39,150
2022-08-16 2022-08-12 S Sale
47,000 -33.6%
38.60
US$1,814,200
47,000 -33.6% 38.60 US$1,814,200
2022-08-16 2022-08-12 S Sale
43,135 -23.6%
37.91
US$1,635,248
43,135 -23.6% 37.91 US$1,635,248